{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:42:16Z","timestamp":1791916936246,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Colombiana de Psiquiatr\u00eda (English ed.)"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.rcpeng.2019.10.006","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:03:25Z","timestamp":1635984205000},"page":"290-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuroleptic malignant syndrome in children and adolescents: Systematic review of case reports"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-723X","authenticated-orcid":false,"given":"Deborah","family":"Le\u00f3n-Amenero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-9545","authenticated-orcid":false,"given":"Jeff","family":"Huarcaya-Victoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcpeng.2019.10.006_bib0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.9758\/cpn.2017.15.1.76","article-title":"Neuroleptic malignant syndrome associated with valproate in an adolescent","volume":"15","author":"Yildirim","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00004583-199902000-00018","article-title":"Neuroleptic malignant syndrome in children and adolescents","volume":"38","author":"Silva","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0015","first-page":"273","article-title":"Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome","volume":"101","author":"Vurucu","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1941875210386491","article-title":"Neuroleptic malignant syndrome: a review for neurohospitalists","volume":"1","author":"Berman","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajp.2017.05.004","article-title":"Neuroleptic malignant syndrome: a neuro-psychiatric emergency: recognition, prevention, and management","volume":"29","author":"Velamoor","year":"2017","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12028-015-0162-5","article-title":"Neuroleptic malignant syndrome: complications, outcomes, and mortality","volume":"24","author":"Modi","year":"2016","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0035","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0040","article-title":"A mixed presentation of serotonin syndrome vs. neuroleptic malignant syndrome in a 12-year-old boy","author":"Sun","year":"2018","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/0253-7176.203115","article-title":"Leukodystrophy presenting as hyperactivity and bipolarity with uncommon adverse drug reaction","volume":"39","author":"Sutar","year":"2017","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0050","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/cap.2016.0180","article-title":"Neuroleptic malignant syndrome\/malignant catatonia in child psychiatry: literature review and a case series","volume":"27","author":"Ghaziuddin","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0055","doi-asserted-by":"crossref","first-page":"e1246","DOI":"10.1097\/MJT.0000000000000320","article-title":"Neuroleptic malignant syndrome associated with metoclopramide use in a boy: case report and review of the literature","volume":"23","author":"Wittmann","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/cap.2015.0185","article-title":"Treatment of neuroleptic malignant syndrome with electroconvulsive therapy in an adolescent with psychosis","volume":"26","author":"Tanidir","year":"2016","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/cap.2014.0125","article-title":"A complex presentation of pediatric neuroleptic malignant syndrome related to polypharmacy in a 12-year-old male","volume":"26","author":"Sharon","year":"2016","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40519-015-0247-3","article-title":"Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa","volume":"21","author":"Ayyildiz","year":"2016","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1542\/pir.36.7.313","article-title":"Index of suspicion. Case 2: fever and Irritability in a 15-year-old boy with autism","volume":"36","author":"Westfall","year":"2015","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/cap.2015.29000.bjc","article-title":"Neuroleptic malignant syndrome in a boy with NMDA receptor encephalitis","volume":"25","author":"Berg","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0085","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s12098-013-1323-1","article-title":"A case of neuroleptic malignant syndrome in an infant","volume":"81","author":"Kailas","year":"2014","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0090","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00431-013-2208-z","article-title":"Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency","volume":"173","author":"Butwicka","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0095","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-008908","article-title":"Combination of Steven-Johnson syndrome and neuroleptic malignant syndrome following carbamazepine therapy: a rare occurrence","volume":"2013","author":"Sharma","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pmrj.2011.11.008","article-title":"Neuroleptic malignant syndrome associated with the use of carbidopa\/levodopa for dystonia in persons with cerebral palsy","volume":"4","author":"Perry","year":"2012","journal-title":"PM R"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1089\/cap.2011.0131","article-title":"Clozapine-induced neuroleptic malignant syndrome in an adolescent","volume":"22","author":"Matheson","year":"2012","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00540-011-1269-2","article-title":"Anesthetic management of a pediatric patient with neuroleptic malignant syndrome","volume":"26","author":"Bhalla","year":"2012","journal-title":"J Anesth"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0115","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1176\/jnp.23.1.jnpe14","article-title":"Paliperidone-induced neuroleptic malignant syndrome","volume":"23","author":"Nayak","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0120","first-page":"405","article-title":"Neuroleptic malignant syndrome in adolescents: Four probable cases in the Western Cape","volume":"101","author":"Henderson","year":"2011","journal-title":"S Afr Med J"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0125","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.4081\/pr.2011.e19","article-title":"Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus","volume":"3","author":"Arslankoylu","year":"2011","journal-title":"Pediatr Rep"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2146\/ajhp090091","article-title":"Possible contribution of XYY syndrome to neuroleptic malignant syndrome in a child receiving quetiapine","volume":"67","author":"Randolph","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/2009.4.PEDS08444","article-title":"Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article","volume":"4","author":"Wait","year":"2009","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/cap.2008.1821","article-title":"Atypical neuroleptic malignant syndrome in an adolescent","volume":"18","author":"Rais","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1460-9592.2006.02079.x","article-title":"Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy","volume":"17","author":"Tsuchiya","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.WNF.0000240941.13876.5E","article-title":"Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient","volume":"30","author":"Palakurthi","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/15563650601031692","article-title":"Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl","volume":"45","author":"Erermis","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10673220701551110","article-title":"\u00abAtypical\u00bb neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes","volume":"15","author":"Choi-Kain","year":"2007","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0165","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/jnp.2006.18.4.552","article-title":"Persistent amnesia as a sequel of olanzapine-induced neuroleptic malignant syndrome","volume":"18","author":"Mendhekar","year":"2006","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0170","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/7010.2006.00234","article-title":"Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child","volume":"21","author":"Martinez","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/01.chi.0000209786.29479.74","article-title":"Neuroleptic malignant syndrome and aripiprazole","volume":"45","author":"Hammerman","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0180","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/01.chi.0000177328.92333.2b","article-title":"NMS after clozapine initiation","volume":"44","author":"Skarpathiotakis","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0185","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/cap.2005.15.844","article-title":"Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia","volume":"15","author":"Mane","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0190","first-page":"1225","article-title":"[Malignant neuroleptic syndrome and polyserositis associated to clozapine use: report of one case]","volume":"133","author":"Eymin","year":"2005","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/IJAMH.2005.17.2.187","article-title":"Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome","volume":"17","author":"Dew","year":"2005","journal-title":"Int J Adolesc Med Health"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0200","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/0269881105053310","article-title":"Neuroleptic malignant syndrome due to three atypical antipsychotics in a child","volume":"19","author":"Chungh","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/IJAMH.2004.16.2.179","article-title":"Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents","volume":"16","author":"Zalsman","year":"2004","journal-title":"Int J Adolesc Med Health"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0210","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.chi.0000142277.95052.94","article-title":"Aripiprazole and atypical neuroleptic malignant syndrome","volume":"43","author":"Spalding","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0215","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0149-2918(04)90182-8","article-title":"Neuroleptic malignant syndrome associated with ziprasidone in an adolescent","volume":"26","author":"Leibold","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0220","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/cap.2004.14.481","article-title":"Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine","volume":"14","author":"Hanft","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0225","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1081\/CLT-200035214","article-title":"Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic","volume":"42","author":"Abu-Kishk","year":"2004","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1592\/phco.23.2.255.32091","article-title":"Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy","volume":"23","author":"Berry","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00431-002-0956-2","article-title":"Neuroleptic malignant syndrome in a 4-year-old girl associated with alimemazine","volume":"161","author":"Van Maldegem","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00124509-200206000-00006","article-title":"ECT treatment of malignant catatonia\/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment","volume":"18","author":"Ghaziuddin","year":"2002","journal-title":"J ECT"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0245","first-page":"157","article-title":"Neuroleptic malignant syndrome in children and adolescents","volume":"16","author":"Ty","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0250","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1023\/A:1012480130445","article-title":"Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy","volume":"24","author":"Rubio-Gozalbo","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0255","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s004310100743","article-title":"Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy","volume":"160","author":"Ito","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0260","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/cap.2000.10.327","article-title":"Case study. Risperidone-induced neuroleptic malignant syndrome in an adolescent","volume":"10","author":"Robb","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0265","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/PEC.0000000000001000","article-title":"Acute Dystonia versus neuroleptic malignant syndrome without fever in an eight-year-old child.","volume":"33","author":"Sridaran","year":"2017","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0270","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1089\/cap.2016.0102","article-title":"Agitation management in pediatric males with anti-N-methyl-D-aspartate receptor encephalitis","volume":"26","author":"Schumacher","year":"2016","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0275","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/JCP.0000000000000548","article-title":"Neurological, metabolic, and psychiatric adverse events in children and adolescents treated with aripiprazole","volume":"36","author":"Jakobsen","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0280","first-page":"535","article-title":"Neuroleptic malignant syndrome associated with metoclopramide in a child","volume":"56","author":"Yaman","year":"2014","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0285","first-page":"220","article-title":"Association of atypical neuroleptics with anticonvulsants and malignant syndrome. Report of 2 cases","volume":"18","author":"Nabih","year":"2014","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0290","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1590\/S0004-282X2011000600005","article-title":"Neuroleptic malignant syndrome","volume":"69","author":"Moscovich","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/cap.2008.18502","article-title":"Psychosis or atypical neuroleptic malignant syndrome in an adolescent?","volume":"18","author":"Groff","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0300","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1590\/S1516-44462008000100015","article-title":"Use of olanzapine in adolescent with bipolar disorder after neuroleptic malignant syndrome","volume":"30","author":"Boarati","year":"2008","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0305","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/0028-3886.32793","article-title":"The neuroleptic malignant syndrome: a report of 14 cases from North India","volume":"55","author":"Panagariya","year":"2007","journal-title":"Neurol India"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0310","first-page":"2155","article-title":"Neuroleptic malignant syndrome: a review and report of six cases","volume":"89","author":"Kasantikul","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006565-200304000-00009","article-title":"Viral encephalitis complicated by neuroleptic malignant syndrome in a 7-year-old girl","volume":"19","author":"Hillis","year":"2003","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0320","first-page":"976","article-title":"[Electroconvulsive therapy in the adolescent: clinical considerations apropos of a series of cases]","volume":"46","author":"Etain","year":"2001","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0325","series-title":"Tratado de psiquiatr\u00eda del ni\u00f1o y del adolescente","author":"Mardomingo","year":"2015"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0330","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/cap.2008.0130","article-title":"Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review","volume":"19","author":"Neuhut","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0335","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0340","series-title":"Catatonia. A clinician\u2019s guide to diagnosis and treatment","author":"Fink","year":"2003"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0345","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0350","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00004583-199211000-00028","article-title":"Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome","volume":"31","author":"Woodbury","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0355","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/01.chi.0000142280.87429.68","article-title":"Practice parameter for use of electroconvulsive therapy with adolescents","volume":"43","author":"Ghaziuddin","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.rcpeng.2019.10.006_bib0360","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/j.1440-1614.1999.00630.x","article-title":"Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases","volume":"33","author":"Trollor","year":"1999","journal-title":"Aust N Z J Psychiatry"}],"container-title":["Revista Colombiana de Psiquiatr\u00eda (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530312021000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530312021000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:26:27Z","timestamp":1762867587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530312021000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2530312021000977"],"URL":"https:\/\/doi.org\/10.1016\/j.rcpeng.2019.10.006","relation":{},"ISSN":["2530-3120"],"issn-type":[{"value":"2530-3120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroleptic malignant syndrome in children and adolescents: Systematic review of case reports","name":"articletitle","label":"Article Title"},{"value":"Revista Colombiana de Psiquiatr\u00eda (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcpeng.2019.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rcp.2019.10.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Asociaci\u00f3n Colombiana de Psiquiatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}